Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo Nordisk’s Wegovy shed more than 33 pounds